| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/31/2008 | EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 12/31/2008 | EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 12/31/2008 | EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 12/31/2008 | EP1294872B1 Human trp-like calcium channel protein-2 (tlcc-2) |
| 12/31/2008 | EP1272527B1 Preparation of antibodies having adcc via cd16, such as anti-rhesus d monoclonal antibodies |
| 12/31/2008 | EP1266009B1 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 12/31/2008 | EP1192260B1 Arabidopsis thaliana cdc27 homologs |
| 12/31/2008 | EP1149169B1 Methods of use of a novel lysyl oxidase-related protein |
| 12/31/2008 | EP1113810B1 Methods of treating multiple myeloma and myeloma-induced bone resorption using antagonists of integrin / receptor binding |
| 12/31/2008 | EP1032672B1 Dna19355 polypeptide, a tumor necrosis factor homolog |
| 12/31/2008 | EP1028751B1 Methods and compositions comprising glycoprotein glycoforms |
| 12/31/2008 | EP0937153B1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 12/31/2008 | EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/31/2008 | CN101336375A Method for detection of virulent strain of influenza type-A virus |
| 12/31/2008 | CN101336249A 新型肽化合物 Novel peptide compounds |
| 12/31/2008 | CN101334356A Gas sensors |
| 12/31/2008 | CN101333516A Chimeric animal and method for producing the same |
| 12/31/2008 | CN101333257A Broadspectrum specificity polyclone antibody of methoxyl organophosphorus pesticide and uses thereof |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333255A BP180 single chain antibody of humanized anti-bullous pemphigoid antigen |
| 12/31/2008 | CN101333254A Method for preparing drosophila melanogaster antimicrobial peptide |
| 12/31/2008 | CN101333253A Monoclonal antibodies of anti-human III type precollagen amino terminal peptide and uses thereof |
| 12/31/2008 | CN101333244A Protein purification by ion exchange chromatography |
| 12/31/2008 | CN100447244C BAFF receptor (BCMA), immunoregulatory agent |
| 12/31/2008 | CN100447159C Antibodies to ED-8 domain of fibronectin, their construction and uses |
| 12/31/2008 | CN100447158C Neutralizable epitope of HGF and neutralizing antibody binding to the same |
| 12/31/2008 | CN100447157C Androgen receptor compound relative protein |
| 12/31/2008 | CN100447156C T2R taste receptors and genes encoding same |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CA2691785A1 Complexes of il-15 and il-15ralpha and uses thereof |
| 12/31/2008 | CA2691166A1 Polypeptides and polynucleotides for artemin and related ligands, and methods of use thereof |
| 12/31/2008 | CA2689941A1 Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 12/31/2008 | CA2689408A1 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease |
| 12/31/2008 | CA2689064A1 Sequence based engineering and optimization of single chain antibodies |
| 12/31/2008 | CA2688667A1 Methods of treating rsv infections and related conditions |
| 12/30/2008 | US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 12/30/2008 | US7470775 Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins |
| 12/30/2008 | US7470774 Anti-pro1477 antibodies |
| 12/30/2008 | US7470773 Monoclonal antibodies for binding immunoglobins |
| 12/30/2008 | US7470772 Antibody that specifically binds to Chemerin receptor ligand precursor |
| 12/30/2008 | US7470665 Antiproliferatory agents; antitumor agents; mixture of fibroblast growth factor and cytolysis agent |
| 12/30/2008 | US7470510 Methods for diagnosing cancer and determining a susceptibility for developing cancer |
| 12/30/2008 | US7470432 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 12/30/2008 | US7470428 Compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is |
| 12/30/2008 | CA2353048C Pharmaceutical composition useful in the prevention or treatment of peptic ulcers |
| 12/30/2008 | CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules |
| 12/28/2008 | CA2634144A1 Novel fish pathogen |
| 12/25/2008 | US20080319173 Blood group antigen fusion polypeptides and methods of use thereof |
| 12/25/2008 | US20080319172 Construct comprising two antigen binding sites where both have a moiety with a molecule binding region and a molecule non-binding region; detecting protein having certain amino acid sequences |
| 12/25/2008 | US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide |
| 12/25/2008 | US20080318872 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/25/2008 | US20080318860 High Activity Growth Factor Mutants |
| 12/25/2008 | US20080318853 Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin |
| 12/25/2008 | US20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 12/25/2008 | US20080318835 Novel Integrin Ligand ITGL-TSP |
| 12/25/2008 | US20080318790 Process for the Production of Fine Chemicals |
| 12/25/2008 | US20080318339 Sensing Device and Method For Determination of Teh Amount of Target Molecule in an Analyte |
| 12/25/2008 | US20080318337 Method for Determining a Tissue Degradation Process by Detection of Comp Neoepitopes |
| 12/25/2008 | US20080318297 Inhibition of Infiltration, and Cell Killing Agent |
| 12/25/2008 | US20080318257 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders; hybridoma cell line; radioimmunoassay; kits |
| 12/25/2008 | US20080318254 PSCA antibodies and hybridomas producing them |
| 12/25/2008 | US20080318253 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 12/25/2008 | US20080318251 G protein coupled receptors for use as tools in identifying modulators of taste perception |
| 12/25/2008 | US20080318250 Compositions and Methods for Identifying Sperm for Forensic Applications |
| 12/25/2008 | US20080318239 Compositions and methods for the diagnosis and treatment of tumor |
| 12/25/2008 | US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 12/25/2008 | US20080318223 Large deletions in human brca1 gene and use thereof |
| 12/25/2008 | US20080318202 Chimeric pancreas |
| 12/25/2008 | US20080317811 Treatment of Cancer Using Tlr3 Agonists |
| 12/25/2008 | US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/25/2008 | US20080317771 Anti-Clusterin Oligoclonal Antibodies for Diagnosis and Prediction of the Aggressiveness of Tumours, Diagnostic Method and Related Kits |
| 12/25/2008 | US20080317770 Induction of immunological tolerance |
| 12/25/2008 | US20080317766 Costimulatory Molecules and Uses Thereof |
| 12/25/2008 | US20080317765 Method for Removal of Toxins from Mucosal Membranes |
| 12/25/2008 | US20080317763 Regulation of Metalloprotease Cleavage of Cell Surface Proteins |
| 12/25/2008 | US20080317760 Compositions and Methods for Diagnosing and Treating Cancer |
| 12/25/2008 | US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 12/25/2008 | US20080317757 Human monoclonal antibody binding to hGM-CSF and its antigen binding portion |
| 12/25/2008 | US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/25/2008 | US20080317754 Human Osteoclast Derived Cathepsin |
| 12/25/2008 | US20080317751 Idiotype Vaccination with Bispecific and Multispecific Immunoglobulin Molecules |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 12/25/2008 | US20080317747 Recombinant anti-cd30 antibodies and uses thereof |
| 12/25/2008 | US20080317746 Anti-Il2 Antibodies |
| 12/25/2008 | US20080317743 Human Artificial Chromosome Containing Human Antibody Lambda Light Chain Gene And Non-Human Animal Containing The Human Artificial Chromosome Capable Of Genetic Transmission |
| 12/25/2008 | US20080317731 Phospholipases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 12/25/2008 | US20080317710 Methods For Treating Autoimmune or Demyelinating Diseases |
| 12/25/2008 | US20080317669 Cloning of honey bee allergen C |
| 12/24/2008 | WO2008157776A2 Modified diphtheria toxins |
| 12/24/2008 | WO2008157729A2 Methods for predicting three-dimensional structures for alpha helical membrane proteins and their use in design of selective ligands |
| 12/24/2008 | WO2008157379A2 Covalent diabodies and uses thereof |
| 12/24/2008 | WO2008157356A2 Antibody formulations |
| 12/24/2008 | WO2008157263A2 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same |
| 12/24/2008 | WO2008157161A1 Anti-il-20 antibody and its use in treating il-20 associated inflammatory diseases |
| 12/24/2008 | WO2008156833A2 G2a receptor as a therapeutic target |
| 12/24/2008 | WO2008156713A2 Anti-cd20 therapeutic compositions and methods |
| 12/24/2008 | WO2008156712A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | WO2008156709A1 Il-17 heteromeric receptor complex |
| 12/24/2008 | WO2008156704A2 Antibody-mediated modulation of allergy |